by Ming Li
In 2010, we made the first clinical study. In 2013, we registered a company for development of this invention. In 2014, we got the first prototype of product. it was ok for prostatitis or nephritis if the operator was sophisticately skilled, But for bone problems, it was not satisfied. The problem was, a commercial transducer was not powerful enough so we developed the transducer by ourself. now we have finished the design of the transducer and the product cures a patient of transverse myelitis without any damage to the bone marrow. The patient of myelitis was the first customer, she strongly asked for purchase for further treatment in the future. My team members Guan and Lin are also business partner, they was suppliers and now participate the manufacturing of the product by their ask. This invention had presented three times at AIUM annual conventions.
Production Manager, Bachelor
Biography: With many years experience of plastic processing, he is familiar with standards and arts of products of plastic
Title: Production Manager
Advanced Degree(s): Bachelor
electrical manager, Bachelor
Biography: he is an expert not only of ultrasound but also of electrical standards
Title: electrical manager
Advanced Degree(s): Bachelor
The key milestones that we have been achieved are that we finish the design of the product which cure a patient of transverse myelitis, and the assembling of big lot of the product is beginning.
we expected to get liscense from FDA in six to eight months.
Our competitive power is from our comprehensive understanding of this technology. we will make our efforts to make the best products at the lowest cost, give the customers the best service.
We filed 3 patents in China, India and Japan where competitors are easy to emerge, we will still keep secrets about standards of the innovation and informations about components especially that we produce by ourself.
We don't need to much funding, I funded the project by myself until now and I have no loan. I am raising funding in China by brokers and they are working now.
The potential market is difficult to anticipate, because we are not clear the application scale of this invention. Acording our initial studies, this technique can surely cure prostatitis, ankylosing spondylitis, arthritis, nephritis, pulpitis and transverse myelitis. It may benefit chemotherapies of cancer although we did not make a trial.
In general,market is not a problem for company growth.
Projected 3 Year Growth
In three years, we will start all businesses related to infectious diseases mentioned above, and will produce 10M in revenue in 2020.
Before we get liscense, we will supply products for researchers or institutions for academic research, or for patients who are willing to buy it as custom product, in this stage, our purpose is not make money, but let more people know the technology. After we get liscense, we will expand the business as fast as possible all over the world.
As a breakthrough of technology, no other technique can compete with this invention. Our component supplies and product standards are unique, so this is no others can follow in our footsteps.
Professionals who are interested to investigate the technique and institutions who are seeking solutions of problems
Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.